These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32065772)

  • 1. The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.
    Agarwala A; Michos ED; Samad Z; Ballantyne CM; Virani SS
    Circulation; 2020 Feb; 141(7):592-599. PubMed ID: 32065772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women?
    Wenger NK
    Clin Cardiol; 2011 Sep; 34(9):520-3. PubMed ID: 21905040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juggling Multiple Guidelines: A Woman's Heart in the Balance.
    Wenger NK
    J Womens Health (Larchmt); 2016 Mar; 25(3):213-21. PubMed ID: 26771424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
    El Khoudary SR; Aggarwal B; Beckie TM; Hodis HN; Johnson AE; Langer RD; Limacher MC; Manson JE; Stefanick ML; Allison MA;
    Circulation; 2020 Dec; 142(25):e506-e532. PubMed ID: 33251828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique cardiovascular risk factors in women.
    Young L; Cho L
    Heart; 2019 Nov; 105(21):1656-1660. PubMed ID: 31315936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines.
    Pavlović J; Greenland P; Franco OH; Kavousi M; Ikram MK; Deckers JW; Ikram MA; Leening MJG
    Circ Cardiovasc Qual Outcomes; 2021 Sep; 14(9):e007183. PubMed ID: 34546786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.
    Cho L; Davis M; Elgendy I; Epps K; Lindley KJ; Mehta PK; Michos ED; Minissian M; Pepine C; Vaccarino V; Volgman AS;
    J Am Coll Cardiol; 2020 May; 75(20):2602-2618. PubMed ID: 32439010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients?
    Seely EW; Tsigas E; Rich-Edwards JW
    Semin Perinatol; 2015 Jun; 39(4):276-83. PubMed ID: 26117165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is cardiovascular disease in women inevitable?: preparing for menopause and beyond.
    Johannes J; Bairey Merz CN
    Cardiol Rev; 2011; 19(2):76-80. PubMed ID: 21285667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular diseases in American women.
    Zhang Y
    Nutr Metab Cardiovasc Dis; 2010 Jul; 20(6):386-93. PubMed ID: 20554179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
    Pagidipati NJ; Navar AM; Mulder H; Sniderman AD; Peterson ED; Pencina MJ
    JAMA; 2017 Apr; 317(15):1563-1567. PubMed ID: 28418481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing Cardiovascular Risk Across the Arc of a Woman's Life: Sex-Specific Prevention and Treatment.
    Verghese D; Muller L; Velamakanni S
    Curr Cardiol Rep; 2023 Sep; 25(9):1053-1064. PubMed ID: 37498450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.
    Gupta K; Kakar TS; Jain V; Gupta M; Al Rifai M; Slipczuk L; Nambi V; Bittner V; Blumenthal RS; Stone NJ; Lavie CJ; Virani SS
    Prog Cardiovasc Dis; 2022; 75():78-82. PubMed ID: 36038004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women.
    Wenger NK
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):118-9. PubMed ID: 20233978
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the spectrum of cardiovascular risk in women - A primer for prevention.
    Satish P; Avenatti E; Patel J; Agarwala A
    Prog Cardiovasc Dis; 2024; 84():34-42. PubMed ID: 38710313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing cardiovascular disease in women.
    Hayes SN
    Am Fam Physician; 2006 Oct; 74(8):1331-40. PubMed ID: 17087427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse pregnancy outcomes and cardiovascular risk factor management.
    Mehta PK; Minissian M; Bairey Merz CN
    Semin Perinatol; 2015 Jun; 39(4):268-75. PubMed ID: 26159741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the American Heart Association cardiovascular disease prevention guideline for women.
    Hsia J; Rodabough RJ; Manson JE; Liu S; Freiberg MS; Graettinger W; Rosal MC; Cochrane B; Lloyd-Jones D; Robinson JG; Howard BV;
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):128-34. PubMed ID: 20160160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular prevention in women: a narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease'.
    Mattioli AV; Sciomer S; Moscucci F; Maiello M; Cugusi L; Gallina S; Dei Cas A; Lombardi C; Pengo M; Parati G; Barilla F; Ciccone MM; Palmiero P; Mercuro G; Maffei S
    J Cardiovasc Med (Hagerstown); 2019 Sep; 20(9):575-583. PubMed ID: 31246698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.